Home > > > > > Report Detail

China Neuromyelitis Optica Drug Market Report & Forecast 2021-2027

Publisher Name :
Date: 27-Aug-2021
No. of pages: 90
Inquire Before Buying

This report contains market size and forecasts of Neuromyelitis Optica Drug in China, including the following market information:

China Neuromyelitis Optica Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

China top five Neuromyelitis Optica Drug companies in 2020 (%)

The global Neuromyelitis Optica Drug market size is expected to growth from US$ 43 million in 2020 to US$ 56 million by 2027; it is expected to grow at a CAGR of 3.0% during 2021-2027.

The China Neuromyelitis Optica Drug market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Neuromyelitis Optica Drug Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Neuromyelitis Optica Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Neuromyelitis Optica Drug Market Segment Percentages, By Type, 2020 (%)

- Glucocorticoids

- Immunotherapies

- Others

China Neuromyelitis Optica Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Neuromyelitis Optica Drug Market Segment Percentages, By Application, 2020 (%)

- Acute Attack

- Remission Prophylactic Treatment

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neuromyelitis Optica Drug revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Neuromyelitis Optica Drug revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer

- Fresenius

- Teva

- Sandoz

- Intas

- Gyjtrs

- NANG KUANG

- Tianjin Kingyork

- Baxter

- CSL

- Grifols

- Octapharma

- CBOP

China Neuromyelitis Optica Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Neuromyelitis Optica Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Neuromyelitis Optica Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Neuromyelitis Optica Drug Overall Market Size
2.1 China Neuromyelitis Optica Drug Market Size: 2021 VS 2027
2.2 China Neuromyelitis Optica Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuromyelitis Optica Drug Players in China Market
3.2 Top China Neuromyelitis Optica Drug Companies Ranked by Revenue
3.3 China Neuromyelitis Optica Drug Revenue by Companies
3.4 Top 3 and Top 5 Neuromyelitis Optica Drug Companies in China Market, by Revenue in 2020
3.5 Companies Neuromyelitis Optica Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuromyelitis Optica Drug Players in China Market
3.6.1 List of Tier 1 Neuromyelitis Optica Drug Companies in China
3.6.2 List of Tier 2 and Tier 3 Neuromyelitis Optica Drug Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Neuromyelitis Optica Drug Market Size Markets, 2021 & 2027
4.1.2 Glucocorticoids
4.1.3 Immunotherapies
4.1.4 Others
4.2 By Type - China Neuromyelitis Optica Drug Revenue & Forecasts
4.2.1 By Type - China Neuromyelitis Optica Drug Revenue, 2016-2021
4.2.2 By Type - China Neuromyelitis Optica Drug Revenue, 2022-2027
4.2.3 By Type - China Neuromyelitis Optica Drug Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Neuromyelitis Optica Drug Market Size, 2021 & 2027
5.1.2 Acute Attack
5.1.3 Remission Prophylactic Treatment
5.2 By Application - China Neuromyelitis Optica Drug Revenue & Forecasts
5.2.1 By Application - China Neuromyelitis Optica Drug Revenue, 2016-2021
5.2.2 By Application - China Neuromyelitis Optica Drug Revenue, 2022-2027
5.2.3 By Application - China Neuromyelitis Optica Drug Revenue Market Share, 2016-2027
6 Neuromyelitis Optica Drug Companies Profiles
6.1 Pfizer
6.1.1 Pfizer Company Details
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Neuromyelitis Optica Drug Introduction
6.1.4 Pfizer Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.1.5 Pfizer Recent Developments
6.2 Fresenius
6.2.1 Fresenius Company Details
6.2.2 Fresenius Business Overview
6.2.3 Fresenius Neuromyelitis Optica Drug Introduction
6.2.4 Fresenius Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.2.5 Fresenius Recent Developments
6.3 Teva
6.3.1 Teva Company Details
6.3.2 Teva Business Overview
6.3.3 Teva Neuromyelitis Optica Drug Introduction
6.3.4 Teva Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.3.5 Teva Recent Developments
6.4 Sandoz
6.4.1 Sandoz Company Details
6.4.2 Sandoz Business Overview
6.4.3 Sandoz Neuromyelitis Optica Drug Introduction
6.4.4 Sandoz Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.4.5 Sandoz Recent Developments
6.5 Intas
6.5.1 Intas Company Details
6.5.2 Intas Business Overview
6.5.3 Intas Neuromyelitis Optica Drug Introduction
6.5.4 Intas Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.5.5 Intas Recent Developments
6.6 Gyjtrs
6.6.1 Gyjtrs Company Details
6.6.2 Gyjtrs Business Overview
6.6.3 Gyjtrs Neuromyelitis Optica Drug Introduction
6.6.4 Gyjtrs Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.6.5 Gyjtrs Recent Developments
6.7 NANG KUANG
6.7.1 NANG KUANG Company Details
6.7.2 NANG KUANG Business Overview
6.7.3 NANG KUANG Neuromyelitis Optica Drug Introduction
6.7.4 NANG KUANG Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.7.5 NANG KUANG Recent Developments
6.8 Tianjin Kingyork
6.8.1 Tianjin Kingyork Company Details
6.8.2 Tianjin Kingyork Business Overview
6.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Introduction
6.8.4 Tianjin Kingyork Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.8.5 Tianjin Kingyork Recent Developments
6.9 Baxter
6.9.1 Baxter Company Details
6.9.2 Baxter Business Overview
6.9.3 Baxter Neuromyelitis Optica Drug Introduction
6.9.4 Baxter Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.9.5 Baxter Recent Developments
6.10 CSL
6.10.1 CSL Company Details
6.10.2 CSL Business Overview
6.10.3 CSL Neuromyelitis Optica Drug Introduction
6.10.4 CSL Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.10.5 CSL Recent Developments
6.11 Grifols
6.11.1 Grifols Company Details
6.11.2 Grifols Business Overview
6.11.3 Grifols Neuromyelitis Optica Drug Introduction
6.11.4 Grifols Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.11.5 Grifols Recent Developments
6.12 Octapharma
6.12.1 Octapharma Company Details
6.12.2 Octapharma Business Overview
6.12.3 Octapharma Neuromyelitis Optica Drug Introduction
6.12.4 Octapharma Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.12.5 Octapharma Recent Developments
6.13 CBOP
6.13.1 CBOP Company Details
6.13.2 CBOP Business Overview
6.13.3 CBOP Neuromyelitis Optica Drug Introduction
6.13.4 CBOP Neuromyelitis Optica Drug Revenue in China Market (2016-2021)
6.13.5 CBOP Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Neuromyelitis Optica Drug Market Opportunities & Trends in China Market
Table 2. Neuromyelitis Optica Drug Market Drivers in China Market
Table 3. Neuromyelitis Optica Drug Market Restraints in China Market
Table 4. Key Players of Neuromyelitis Optica Drug in China Market
Table 5. Top Neuromyelitis Optica Drug Players in China Market, Ranking by Revenue (2019)
Table 6. China Neuromyelitis Optica Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Neuromyelitis Optica Drug Revenue Share by Companies, 2016-2021
Table 8. Companies Neuromyelitis Optica Drug Product Type
Table 9. List of Tier 1 Neuromyelitis Optica Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Neuromyelitis Optica Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Neuromyelitis Optica Drug Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Neuromyelitis Optica Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Neuromyelitis Optica Drug Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Neuromyelitis Optica Drug Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Neuromyelitis Optica Drug Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Neuromyelitis Optica Drug Revenue (US$, Mn), 2022-2027
Table 17. Pfizer Company Details
Table 18. Pfizer Business Overview
Table 19. Pfizer Neuromyelitis Optica Drug Product
Table 20. Pfizer Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Pfizer Recent Developments
Table 22. Fresenius Company Details
Table 23. Fresenius Business Overview
Table 24. Fresenius Neuromyelitis Optica Drug Product
Table 25. Fresenius Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Fresenius Recent Developments
Table 27. Teva Company Details
Table 28. Teva Business Overview
Table 29. Teva Neuromyelitis Optica Drug Product
Table 30. Teva Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Teva Recent Developments
Table 32. Sandoz Company Details
Table 33. Sandoz Business Overview
Table 34. Sandoz Neuromyelitis Optica Drug Product
Table 35. Sandoz Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Sandoz Recent Developments
Table 37. Intas Company Details
Table 38. Intas Business Overview
Table 39. Intas Neuromyelitis Optica Drug Product
Table 40. Intas Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Intas Recent Developments
Table 42. Gyjtrs Company Details
Table 43. Gyjtrs Business Overview
Table 44. Gyjtrs Neuromyelitis Optica Drug Product
Table 45. Gyjtrs Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Gyjtrs Recent Developments
Table 47. NANG KUANG Company Details
Table 48. NANG KUANG Business Overview
Table 49. NANG KUANG Neuromyelitis Optica Drug Product
Table 50. NANG KUANG Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 51. NANG KUANG Recent Developments
Table 52. Tianjin Kingyork Company Details
Table 53. Tianjin Kingyork Business Overview
Table 54. Tianjin Kingyork Neuromyelitis Optica Drug Product
Table 55. Tianjin Kingyork Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Tianjin Kingyork Recent Developments
Table 57. Baxter Company Details
Table 58. Baxter Business Overview
Table 59. Baxter Neuromyelitis Optica Drug Product
Table 60. Baxter Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Baxter Recent Developments
Table 62. CSL Company Details
Table 63. CSL Business Overview
Table 64. CSL Neuromyelitis Optica Drug Product
Table 65. CSL Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 66. CSL Recent Developments
Table 67. Grifols Company Details
Table 68. Grifols Business Overview
Table 69. Grifols Neuromyelitis Optica Drug Product
Table 70. Grifols Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Grifols Recent Developments
Table 72. Octapharma Company Details
Table 73. Octapharma Business Overview
Table 74. Octapharma Neuromyelitis Optica Drug Product
Table 75. Octapharma Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Octapharma Recent Developments
Table 77. CBOP Company Details
Table 78. CBOP Business Overview
Table 79. CBOP Neuromyelitis Optica Drug Product
Table 80. CBOP Neuromyelitis Optica Drug Revenue in China Market (2016-2021) & (US$ Million)
Table 81. CBOP Recent Developments
List of Figures
Figure 1. Neuromyelitis Optica Drug Segment by Type
Figure 2. Neuromyelitis Optica Drug Segment by Application
Figure 3. China Neuromyelitis Optica Drug Market Overview: 2020
Figure 4. China Neuromyelitis Optica Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Neuromyelitis Optica Drug Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Neuromyelitis Optica Drug Revenue in 2020
Figure 7. By Type - China Neuromyelitis Optica Drug Revenue Market Share, 2016-2027
Figure 8. By Application - China Neuromyelitis Optica Drug Revenue Market Share, 2016-2027
Figure 9. Pfizer Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Fresenius Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Teva Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sandoz Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Intas Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Gyjtrs Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. NANG KUANG Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Tianjin Kingyork Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Baxter Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. CSL Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Grifols Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Octapharma Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. CBOP Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs